1. Wakhloo, AK, Gounis, MJ. Revolution in aneurysm treatment: Flow diversion to cure aneurysms: A paradigm shift. Neurosurgery 2014; 61(Suppl.1): 111–120.
Google Scholar | Crossref | Medline2. Chalouhi, N, Tjoumakaris, S, Phillips, JL, et al. A single pipeline embolization device is sufficient for treatment of intracranial aneurysms. AJNR Am J Neuroradiol 2014; 35: 1562–1566.
Google Scholar | Crossref | Medline | ISI3. Rajah, G, Narayanan, S, Rangel-Castilla, L. Update on flow diverters for the endovascular management of cerebral aneurysms. Neurosurg Focus 2017; 42: E2.
Google Scholar4. Kallmes, DF, Hanel, R, Lopes, D, et al. International retrospective study of the pipeline embolization device: A multicenter aneurysm treatment study. AJNR Am J Neuroradiol 2015; 36: 108–115.
Google Scholar | Crossref | Medline | ISI5. Becske, T, Kallmes, DF, Saatci, I, et al. Pipeline for uncoilable or failed aneurysms: Results from a multicenter clinical trial. Radiology 2013; 267: 858–868.
Google Scholar | Crossref | Medline | ISI6. Becske, T, Brinjikji, W, Potts, MB, et al. Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms: Five-year results of the Pipeline for Uncoilable or Failed Aneurysms Trial. Neurosurgery 2017; 80: 40–48.
Google Scholar | Crossref | Medline7. Sweid, A, Starke, RM, Herial, N, et al. Predictors of complications, functional outcome, and morbidity in a large cohort treated with flow diversion. Neurosurgery 2019; 87; 730–743.
Google Scholar | Medline8. Peret, A, Mine, B, Bonnet, T, et al. Safety and efficacy of a pre-treatment antiplatelet regimen of unruptured intracranial aneurysms: A single-center experience. Neuroradiology 2020; 62: 1029–1041.
Google Scholar | Crossref | Medline9. Xia, P, He, C, Chen, L, et al. Efficacy and safety of prasugrel therapy for intracranial aneurysms with endovascular treatment: A meta-analysis. J Neurol Sci 2019; 397: 174–178.
Google Scholar | Crossref | Medline10. DeGrote, JR, Olafson, EM, Drofa, A, et al. Ticagrelor and acetylsalicylic acid after placement of pipeline embolization device for cerebral aneurysm: A case series. Can J Hosp Pharm 2018; 71: 349–355.
Google Scholar | Medline11. Narata, AP, Amelot, A, Bibi, R, et al. Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: A retrospective single center study of 154 consecutive patients with unruptured aneurysms. Neurosurgery 2019; 84: 77–83.
Google Scholar | Crossref | Medline12. Soize, S, Foussier, C, Manceau, PF, et al. Comparison of two preventive dual antiplatelet regimens for unruptured intracranial aneurysm embolization with flow diverter/disrupter: A matched-cohort study comparing clopidogrel with ticagrelor. J Neuroradiol 2019; 46: 378–383.
Google Scholar | Crossref | Medline13. Texakalidis, P, Bekelis, K, Atallah, E, et al. Flow diversion with the pipeline embolization device for patients with intracranial aneurysms and antiplatelet therapy: A systematic literature review. Clin Neurol Neurosurg 2017; 161: 78–87.
Google Scholar | Crossref | Medline14. Gupta, R, Moore, JM, Griessenauer, CJ, et al. Assessment of dual-antiplatelet regimen for pipeline embolization device placement: A survey of major academic neurovascular centers in the United States. World Neurosurg 2016; 96: 285–292.
Google Scholar | Crossref | Medline15. Platz, J, Guresir, E, Seifert, V, et al. Long-term effects of antiplatelet drugs on aneurysm occlusion after endovascular treatment. J Neurointerv Surg 2012; 4: 345–350.
Google Scholar | Crossref | Medline16. Maragkos, GA, Ascanio, LC, Salem, MM, et al. Predictive factors of incomplete aneurysm occlusion after endovascular treatment with the Pipeline embolization device. J Neurosurg 2019; 16: 132: 1–8.
Google Scholar17. Trivelato, FP, Salles Rezende, MT, Ulhoa, AC, et al. Occlusion rates of intracranial aneurysms treated with the Pipeline embolization device: The role of branches arising from the sac. J Neurosurg 2018; 17: 130: 1–7.
Google Scholar | Crossref | Medline18. Brasiliense, LBC, Aguilar-Salinas, P, Miller, DA, et al. Analysis of predictors and probability of aneurysm occlusion in the internal carotid artery after treatment with Pipeline Embolization Device. World Neurosurg 2017; 107: 641–648.
Google Scholar | Crossref | Medline19. Madaelil, TP, Grossberg, JA, Howard, BM, et al. Aneurysm remnants after flow diversion: clinical and angiographic outcomes. AJNR Am J Neuroradiol 2019; 40: 694–698.
Google Scholar | Medline20. Moshayedi, H, Omofoye, OA, Yap, E, et al. Factors affecting the obliteration rate of intracranial aneurysms treated with a single Pipeline embolization device. World Neurosurg 2017; 104: 205–212.
Google Scholar | Crossref | Medline21. Zhang, Y, Ma, C, Liang, S, et al. Morphologic feature elongation can predict occlusion status following Pipeline embolization of intracranial aneurysms. World Neurosurg 2018; 119: e934–e940.
Google Scholar | Crossref | Medline22. Li, Y, Kim, J, Ahmed, A. Effect of aneurysm morphologic parameters on occlusion rates following pipeline embolization. Clin Neurol Neurosurg 2019; 183: 105395.
Google Scholar | Crossref | Medline23. Bender, MT, Colby, GP, Lin, LM, et al. Predictors of cerebral aneurysm persistence and occlusion after flow diversion: A single-institution series of 445 cases with angiographic follow-up. J Neurosurg 2018; 130: 259–267.
Google Scholar | Crossref | Medline24. Chalouhi, N, Daou, B, Barros, G, et al. Matched comparison of flow diversion and coiling in small, noncomplex intracranial aneurysms. Neurosurgery 2017; 81: 92–97.
Google Scholar | Crossref | Medline25. Chalouhi, N, Tjoumakaris, S, Starke, RM, et al. Comparison of flow diversion and coiling in large unruptured intracranial saccular aneurysms. Stroke 2013; 44: 2150–2154.
Google Scholar | Crossref | Medline | ISI